A/Prof. Susan Ramus
Honorary
Clinical Pathology
31 Scholarly works
0 Projects
HIGHLIGHTS
2020
Journal article
Prognostic gene expression signature for high-grade serous ovarian cancer
DOI: 10.1016/j.annonc.2020.05.0192020
Journal article
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
DOI: 10.1038/s41436-020-0862-x2020
Conference Proceedings
Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer.
DOI: 10.1158/1557-3265.ovca19-b372020
Conference Proceedings
PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer.
DOI: 10.1158/1557-3265.ovca19-a032020
Conference Proceedings
Molecular analysis of exceptional response in high-grade serous ovarian cancer.
DOI: 10.1158/1557-3265.ovca19-ia052018
Journal article
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
DOI: 10.1093/jnci/djx2652016
Journal article
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
DOI: 10.1186/s13058-016-0768-3
RECENT SCHOLARLY WORKS
2016
Journal article
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration
DOI: 10.18632/oncotarget.105462016
Journal article
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
DOI: 10.18632/oncotarget.102152016
Journal article
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
DOI: 10.1158/2159-8290.CD-15-1227